AMGN vs MIRM · P/E 24, rev $10.05B vs rev $336.1M
Amgen Inc (AMGN) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the AMGN and MIRM stock pages for the full models.
Not investment advice.